Predictors and implications of severe hypersplenism in patients with cirrhosis

American Journal of the Medical Sciences

Volumn 326, Issue 3, 2003, Pages 111-116

  Liangpunsakul, Suthat ^b   Ulmer, Brian J ^b   Chalasani, Naga ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Cirrhosis; Hypersplenism; Spontaneous bacterial peritonitis; Variceal bleeding

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; BACTERIAL PERITONITIS; BLEEDING; CLINICAL OBSERVATION; CONFIDENCE INTERVAL; DISEASE SEVERITY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; HYPERSPLENISM; LEUKOCYTE COUNT; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PREVALENCE; REVIEW; RISK; THROMBOCYTE COUNT; TREATMENT INDICATION; UNITED STATES; VARICOSIS;

EID: 0141457204     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200309000-00001     Document Type: Article

References (17)

1. Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol 2001;13:317-23.
2. Shah S, Haynes PC, Allan PL, et al. Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol 1996;91:2580-3.
3. Bashour FN, Teran JC, Mullen KD. Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 2000;95:2936-9.
4. Mutchnik MG, Lerner E, Conn HO. Effect of porto-caval anastomosis on hypersplenism. Dig Dis Sci 1980;25:929-38.
5. Soper NJ, Rikkers LF. Cirrhosis and hypersplenism: clinical and hemodynamic correlates. Curr Surg 1986;43:21-4.
6. Felix WR Jr, Sigel B, Jackson FC. The effect of portocaval shunt on hypersplenism. Surg Gynecol Obstet 1974;139:899-904.
7. Takashi M, Igarashi M, Hino S, et al. Portal hemodynamics in chronic portal systemic encephalopathy. Angiographic study in seven patients. J Hepatol 1985;1:467-76.
8. Westaby S, Wilkinson S, Williams R. Spleen size and portal hypertension in cirrhosis. Digestion 1978;17:63-8.
9. Merkel C, Gatta A, Arnaboldi L, et al. Splenic hemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clin Physiol 1985;5:531-9.
10. Martin TG, Somberg KA, Meng YG, et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med 1997;127:285-8.
11. Peck-Radosavljevic M, Wichlas M, Pidlich J, et al. Blunted thrombopoietin response to interferon-alfa-induced thrombocytopenia during treatment for hepatitis C. Hepatology 1998;28:1424-9.
12. Andreu M, Sola R, Serra AS, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993;104:1133-8.
13. Chalasani N, Imperiale TF, Ismail A, et al. Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999;94:3285-91.
14. Zaman A, Becker T, Lapidus J, et al. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med 2001;161:2564-70.
15. Goulis J, Patch J, Burroughs AK. Bacterial infections in the pathogenesis of variceal bleeding. Lancet 1999;353:139-42.
16. Papatheodoridis GV, Patch D, Webster GJ, et al. Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology 1999;29:1085-90.
17. Goulis J, Armonis A, Patch D, et al. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1998;27:1207-12.